External Audit Findings Closure Authority — Hospital Networks

The mandate

Audit findings across patient revenue, insurer receivables, pharmacy inventory, vendor master data, payroll access and capital projects require systematic closure. Action plans describe policy updates and system tickets but rarely establish affected populations, root causes, operating evidence or sustained remediation.

The nine-month assignment begins within two weeks and covers finding revalidation, two interim testing windows, year-end audit and permanent-owner handover. A failed control test, new exception population, system release or changed hospital process is a mandatory reopening event. Five weeks are reserved for successor overlap, and the assignment cannot extend into a general hospital transformation programme.

Exit requires a reconciled findings universe, consequence-ranked root causes, accountable remediation, complete evidence, independent management testing, transparent residual limitations and three reporting cycles without recurrence. The successor must adjudicate an unseen failed sample in a previously closed revenue control, decide reopening and defend the evidence to the Audit Committee before accepting authority.

The interim may reject cosmetic closures, require full populations, direct remediation sequencing, reassign temporary owners, approve delegated control changes and control ₹280 million within the authorised programme. Process executives own operations; the Controller retains accounting and closure assertions; Internal Audit determines its testing; external auditors retain independent scope and conclusions; the committee approves material risk acceptance.

Clinical practice, care quality, billing tariff design, fraud investigation, technology replacement and external-audit negotiation are excluded. The leader may repair financial interfaces but cannot direct medical decisions or promise auditor acceptance. Findings will remain open where evidence is incomplete, even when public timetables or executive incentives favour nominal closure.

Why this seat is open

Repeated findings show that activity completion was mistaken for control-effectiveness evidence, and the lead’s departure removed accountability just before year-end testing. Temporary authority must challenge closure claims, sustain fixes across real hospital cycles and qualify a permanent owner against an unexpected failure rather than a prepared presentation.

What you will own

• Reconcile all audit findings, management points, related deficiencies, action plans, owners, due dates and closure assertions.
• Rediagnose root cause and affected populations across patient revenue, inventory, vendors, payroll and capital expenditure.
• Define closure evidence for design, implementation, complete-population correction, operating effectiveness and sustained performance.
• Separate closed, risk-accepted, superseded, dependent, partially remediated and reopened items with committee-approved logic.
• Coordinate management testing while preserving Internal Audit and external-auditor independence from programme execution.
• Exercise missing insurer remittance, duplicate vendor, pharmacy count break, privileged access and capitalisation exceptions.
• Transfer authority after three cycles and successor adjudication of an unseen failure in a declared-closed control.

Candidate qualifications

• Held executive financial-control remediation authority across a large hospital, insurer or similarly distributed regulated network.
• Closed recurring audit findings across revenue, receivables, inventory, vendors, payroll, access and fixed assets.
• Distinguished completed actions from tested design, implementation, population correction and sustained operating effectiveness.
• Managed difficult reopening and risk-acceptance decisions without bargaining over independent auditor conclusions.
• Worked with operational, technology, compliance and audit teams while preserving clinical and assurance boundaries.
• Handed a transparent remediation portfolio to permanent leadership through repeated live testing and surprise exceptions.